147 related articles for article (PubMed ID: 11294500)
1. Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
Liu IM; Chi TC; Cheng JT
Horm Metab Res; 2001 Feb; 33(2):96-100. PubMed ID: 11294500
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of neuropeptide Y and its mRNA in STZ-diabetic rats.
Fu M; Li X; Zhang M; Xian Y
Chin Med J (Engl); 2002 May; 115(5):690-5. PubMed ID: 12133536
[TBL] [Abstract][Full Text] [Related]
3. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
[TBL] [Abstract][Full Text] [Related]
4. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats.
Kuo DY
Regul Pept; 2005 Apr; 127(1-3):19-26. PubMed ID: 15680466
[TBL] [Abstract][Full Text] [Related]
5. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
[TBL] [Abstract][Full Text] [Related]
6. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
[TBL] [Abstract][Full Text] [Related]
7. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats.
White JD; Olchovsky D; Kershaw M; Berelowitz M
Endocrinology; 1990 Feb; 126(2):765-72. PubMed ID: 2404748
[TBL] [Abstract][Full Text] [Related]
8. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
Li H; Wei Q
IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
[TBL] [Abstract][Full Text] [Related]
9. Increased endogenous noradrenaline and neuropeptide Y release from the hypothalamus of streptozotocin diabetic rats.
Morris MJ; Pavia JM
Brain Res; 2004 Apr; 1006(1):100-6. PubMed ID: 15047028
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy.
Sahu A; Sninsky CA; Kalra PS; Kalra SP
Endocrinology; 1990 Jan; 126(1):192-8. PubMed ID: 2136723
[TBL] [Abstract][Full Text] [Related]
11. Metformin-like effects of Quei Fu Di Huang Wan, a Chinese herbal mixture, on streptozotocin-induced diabetic rat.
Cheng JT; Liu IM; Chi TC; Su HC; Chang CG
Horm Metab Res; 2001 Dec; 33(12):727-32. PubMed ID: 11753758
[TBL] [Abstract][Full Text] [Related]
12. Effect of vanadium on insulin sensitivity and appetite.
Wang J; Yuen VG; McNeill JH
Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143
[TBL] [Abstract][Full Text] [Related]
13. Involvement of neuropeptide Y in glucose sensing in the dorsal hypothalamus of streptozotocin diabetic rats - in vitro and in vivo studies of transmitter release.
Gozali M; Pavia JM; Morris MJ
Diabetologia; 2002 Sep; 45(9):1332-9. PubMed ID: 12242467
[TBL] [Abstract][Full Text] [Related]
14. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
[TBL] [Abstract][Full Text] [Related]
15. Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):369-72. PubMed ID: 1509205
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
17. Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats.
Thompson KH; Leichter J; McNeill JH
Biochem Biophys Res Commun; 1993 Dec; 197(3):1549-55. PubMed ID: 8280174
[TBL] [Abstract][Full Text] [Related]
18. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
19. Insulin is not a prerequisite for rapid regulation of neuropeptide Y gene transcription in the arcuate nucleus in food-restricted rats.
Goto M; Arima H; Hiroi M; Shimizu H; Watanabe M; Hayashi M; Banno R; Sato I; Ozaki N; Nagasaki H; Oiso Y
Neurosci Lett; 2007 Jun; 420(1):61-5. PubMed ID: 17462823
[TBL] [Abstract][Full Text] [Related]
20. Effect of insulin-mimetic vanadyl sulfate on cytochrome P450 2E1-dependent p-nitrophenol hydroxylation in the liver microsomes of streptozotocin-induced type 1 diabetic rats.
Kataoka S; Yasui H; Hiromura M; Sakurai H
Life Sci; 2005 Oct; 77(22):2814-29. PubMed ID: 15964029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
